Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients

BACKGROUND: Chronic use of Angiotensin-converting enzyme (ACE) inhibitors (ACEi) and aldosterone-receptor blockers (ARB) is not associated with worse outcomes in patients with COVID-19. However, evidence on the impact of their discontinuation during hospital admission is scarce. Our aim was to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Caro-Codón, Juan, Rey, Juan R., Iniesta, Angel M., Rosillo, Sandra O., Castrejon-Castrejon, Sergio, Rodriguez-Sotelo, Laura, Garcia-Veas, Jose M., Marco, Irene, Martinez, Luis A., Martin-Polo, Lorena, Merino, Carlos, Martinez-Cossiani, Marcel, Buño, Antonio, Gonzalez-Valle, Luis, Herrero, Alicia, López-de-Sá, Esteban, Merino, Jose L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234052/
https://www.ncbi.nlm.nih.gov/pubmed/35784098
http://dx.doi.org/10.1016/j.repc.2021.06.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234052/
https://www.ncbi.nlm.nih.gov/pubmed/35784098
http://dx.doi.org/10.1016/j.repc.2021.06.021

Ejemplares similares